, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Fiona Yull

Last active: 3/31/2020

  1. Optimizing Mannose "Click" Conjugation to Polymeric Nanoparticles for Targeted siRNA Delivery to Human and Murine Macrophages. Glass EB, Masjedi S, Dudzinski SO, Wilson AJ, Duvall CL, Yull FE, Giorgio TD (2019) ACS Omega 4(16): 16756-16767
    › Primary publication · 31646220 (PubMed) · PMC6796989 (PubMed Central)
  2. p52 expression enhances lung cancer progression. Saxon JA, Yu H, Polosukhin VV, Stathopoulos GT, Gleaves LA, McLoed AG, Massion PP, Yull FE, Zhao Z, Blackwell TS (2018) Sci Rep 8(1): 6078
    › Primary publication · 29666445 (PubMed) · PMC5904214 (PubMed Central)
  3. IκB Kinase α Is Required for Development and Progression of -Mutant Lung Adenocarcinoma. Vreka M, Lilis I, Papageorgopoulou M, Giotopoulou GA, Lianou M, Giopanou I, Kanellakis NI, Spella M, Agalioti T, Armenis V, Goldmann T, Marwitz S, Yull FE, Blackwell TS, Pasparakis M, Marazioti A, Stathopoulos GT (2018) Cancer Res 78(11): 2939-2951
    › Primary publication · 29588349 (PubMed) · PMC6485619 (PubMed Central)
  4. Immunity drives regulation in cancer through NF-κB. Collignon E, Canale A, Al Wardi C, Bizet M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W, Wilson A, Bouchat S, Hubert P, Van Lint C, Yull F, Sotiriou C, Willard-Gallo K, Noel A, Fuks F (2018) Sci Adv 4(6): eaap7309
    › Primary publication · 29938218 (PubMed) · PMC6010319 (PubMed Central)
  5. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Gupta V, Yull F, Khabele D (2018) Cancers (Basel) 10(10)
    › Primary publication · 30274280 (PubMed) · PMC6210537 (PubMed Central)
  6. p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide Treatment. Saxon JA, Cheng DS, Han W, Polosukhin VV, McLoed AG, Richmond BW, Gleaves LA, Tanjore H, Sherrill TP, Barham W, Yull FE, Blackwell TS (2016) J Immunol 196(4): 1891-9
    › Primary publication · 26773153 (PubMed) · PMC4744539 (PubMed Central)
  7. Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer. McLoed AG, Sherrill TP, Cheng DS, Han W, Saxon JA, Gleaves LA, Wu P, Polosukhin VV, Karin M, Yull FE, Stathopoulos GT, Georgoulias V, Zaynagetdinov R, Blackwell TS (2016) Cell Rep 16(1): 120-132
    › Primary publication · 27320908 (PubMed) · PMC4927403 (PubMed Central)
  8. Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions. Ortega RA, Barham W, Sharman K, Tikhomirov O, Giorgio TD, Yull FE (2016) Int J Nanomedicine : 2163-77
    › Primary publication · 27274241 (PubMed) · PMC4876941 (PubMed Central)
  9. IL-1β and Inflammasome Activity Link Inflammation to Abnormal Fetal Airway Development. Stouch AN, McCoy AM, Greer RM, Lakhdari O, Yull FE, Blackwell TS, Hoffman HM, Prince LS (2016) J Immunol 196(8): 3411-20
    › Primary publication · 26951798 (PubMed) · PMC5315059 (PubMed Central)
  10. Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. Saxon JA, Sherrill TP, Polosukhin VV, Sai J, Zaynagetdinov R, McLoed AG, Gulleman PM, Barham W, Cheng DS, Hunt RP, Gleaves LA, Richmond A, Young LR, Yull FE, Blackwell TS (2016) Oncoimmunology 5(6): e1168549
    › Primary publication · 27471643 (PubMed) · PMC4938365 (PubMed Central)